Aging-related systemic manifestations in COPD patients and cigarette smokers

PLoS One. 2015 Mar 18;10(3):e0121539. doi: 10.1371/journal.pone.0121539. eCollection 2015.

Abstract

Rationale: Chronic obstructive pulmonary disease (COPD) is often associated with age-related systemic abnormalities that adversely affect the prognosis. Whether these manifestations are linked to the lung alterations or are independent complications of smoking remains unclear.

Objectives: To look for aging-related systemic manifestations and telomere shortening in COPD patients and smokers with minor lung destruction responsible for a decline in the diffusing capacity for carbon monoxide (DLCO) corrected for alveolar volume (KCO).

Methods: Cross-sectional study in 301 individuals (100 with COPD, 100 smokers without COPD, and 101 nonsmokers without COPD).

Measurements and main results: Compared to control smokers, patients with COPD had higher aortic pulse-wave velocity (PWV), lower bone mineral density (BMD) and appendicular skeletal muscle mass index (ASMMI), and shorter telomere length (TL). Insulin resistance (HOMA-IR) and glomerular filtration rate (GFR) were similar between control smokers and COPD patients. Smokers did not differ from nonsmokers for any of these parameters. However, smokers with normal spirometry but low KCO had lower ASMMI values compared to those with normal KCO. Moreover, female smokers with low KCO, had lower BMD and shorter TL compared to those with normal KCO.

Conclusions: Aging-related abnormalities in patients with COPD are also found in smokers with minor lung dysfunction manifesting as a KCO decrease. Decreased KCO might be useful, particularly among women, for identifying smokers at high risk for aging-related systemic manifestations and telomere shortening.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aging / blood*
  • Aging / genetics*
  • Aging / pathology
  • Case-Control Studies
  • Cross-Sectional Studies
  • Cytokines / blood
  • Female
  • Humans
  • Male
  • Middle Aged
  • Organ Size
  • Pulmonary Alveoli / pathology
  • Pulmonary Alveoli / physiopathology
  • Pulmonary Disease, Chronic Obstructive / blood
  • Pulmonary Disease, Chronic Obstructive / genetics
  • Pulmonary Disease, Chronic Obstructive / pathology
  • Pulmonary Disease, Chronic Obstructive / physiopathology*
  • Smoking / adverse effects*
  • Spirometry
  • Telomere / genetics

Substances

  • Cytokines

Grants and funding

This research was supported by the Institut National de la Santé et de la Recherche Médicale (INSERM) grant C09-11. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.